Please assess the completion status of the following clinical trial:

Trial Title: Study of Erchonia Low Level Laser Light Therapy to Treat Toenail Fungus

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Onychomycosis present in at least one great toenail, identified as current bacterial/fungal infection classified by the investigator as onychomycosis, with the nail presenting positive on visual inspection for somewhat thickened nail plate with a cloudy appearance and some discoloration (white to yellow to brown).~* Subject is willing and able to refrain from employing other (non-study) treatments (traditional or alternative) for his or her toenail onychomycosis throughout study participation.~* Subject is willing and able to refrain from the use of nail cosmetics such as clear and/or colored nail lacquers throughout study participation.~Exclusion Criteria:~* Spikes of disease extending to nail matrix in the affected great toenail(s).~* Infection involving lunula of the affected toenail(s), e.g., genetic nail disorders, primentary disorders.~* Affected great toenail(s) has less than 2mm clear (unaffected) nail plate length beyond the proximal fold.~* Presence of dermatophytoma (defined as thick masses of fungal hyphae and necrotic keratin between the nail plate and nail bed) on the affected great toenail(s).~* Chronic plantar (moccasin) tinea pedis.~* History of current or past psoriasis of the skin and/or nails.~* Concurrent lichen planus.~* Onychogryphosis.~* Any of the following conditions of the affected great toenail(s) is present: proximal subungual onychomycosis; white superficial onychomycosis; dermatophytoma or yellow spike/streak; exclusively lateral disease~* Confounding problems/abnormalities of the great toenail(s).~* Any abnormality of the affected great toenail(s) that could prevent a normal appearing nail if clearing of infection is achieved.~* Inability for the affected great toenail(s) to become normal in the opinion of the investigator.~* History of multiple repeated failures with previous therapies for onychomycosis.~* Trauma to the affected great toenail(s).~* Use of oral antifungal agents in the past 6 months.~* Use of topical antifungal agents in the past 1 month.~* Prior surgical treatment of the affected great toe(s).~* Subject is unwilling or unable to refrain from employing other (non-study) treatments (traditional and alternative) for his or her toenail onychomycosis throughout study participation.~* Subject is unwilling or unable to refrain from the use of nail cosmetics such as clear and/or colored nail lacquers until the end of study participation.~* Cancer and/or treatment of any type of cancer within the last six months.~* Peripheral vascular disease or peripheral circulatory impairment.~* History of uncontrolled diabetes mellitus.~* Known immunodeficiency.~* Known sensitivity, or contraindication, to light therapy.~* Pregnant, breast feeding, or planning pregnancy prior to the end of study participation.~* Serious mental health illness such as dementia or schizophrenia; psychiatric hospitalization in the past two years.~* Developmental disability or cognitive impairment that would preclude adequate comprehension of the informed consent form and/or ability to follow study subject requirements and/or record the necessary study measurements.~* Involvement in litigation and/or receiving disability benefits related in any way to the parameters of the study.~* Participation in a clinical study or other type of research in the past 30 days.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Erchonia LUNULA (Type: EXPERIMENTAL): The Erchonia LUNULA emits both red light (635 nm) and blue light (405 nm) to the affected toenail for 12 minutes per treatment for 4 treatments, each treatment one week apart.

Based on this trial design, predict the completion outcome and termination type (if applicable).